Skip to content
VitroScreen
  • About
  • Non Clinical
    • Therapeutic areas
    • Microbiome Research Unit
    • Medical Devices
    • Histo-Morphology Platform
  • VitroScreenORA®
  • Regulatory & Consultancy
    • GLP Certified Assays
    • OECD TG 428
    • Sensitization potential by Alternatives
    • Consultancy Unit
  • News
  • Publications
  • Contacts
VitroScreen
  • About
  • Non Clinical
    • Therapeutic areas
    • Microbiome Research Unit
    • Medical Devices
    • Histo-Morphology Platform
  • VitroScreenORA®
  • Regulatory & Consultancy
    • GLP Certified Assays
    • OECD TG 428
    • Sensitization potential by Alternatives
    • Consultancy Unit
  • News
  • Publications
  • Contacts
VitroScreen
  • About
  • Non Clinical
    • Therapeutic areas
    • Microbiome Research Unit
    • Medical Devices
    • Histo-Morphology Platform
  • VitroScreenORA®
  • Regulatory & Consultancy
    • GLP Certified Assays
    • OECD TG 428
    • Sensitization potential by Alternatives
    • Consultancy Unit
  • News
  • Publications
  • Contacts

Archives: Portfolios

  1. Home
  2. Portfolios

S. aureus

P53 PHOSPHO S15

NFKB

MUCIN 1

KI67

ICAM-1

HUMAN BETA DEFENSIN 2

E. coli

CELL DEATH DETECTION FLUORESCEIN

CD14

  • 1
  • 2
  • 3
  • ...
  • 5
  • Next
VitroScreen

VitroScreen s.r.l.

Testing Facility and Headquarter:
via Mosè Bianchi, 103
20149 Milano – Italy


Cap. Soc € 15.000
P. IVA 13454040158
REA MI n. 1653696

Contact

Ph.: 39-02-89077608
Email: infos@vitroscreen.com
Pec: vitroscreen@pec.retesi.it

Linkedin-in

© Copyright 2024| VitroScreen s.r.l. | Privacy Policy | Cookies

VitroScreen part of the SenzaGen Group

© Copyright 2024| VitroScreen s.r.l. Privacy Policy | Cookies

VitroScreen part of the SenzaGen Group